Glenmark Pharmaceuticals - Walk-In Interview for Production, Packing and QA on 25th to 27th April 2019 at GOA
About Glenmark pharmaceutical ltd.
Glenmark was established at a glance standing as an integrated research-based, world pharmaceutical company. Over the decades, we have established ourselves as the leading NCC (new chemical organization) and NBA (new biological organization) as the leading player in the search for both new molecules. We have many molecules in various stages of pre-clinical and clinical development and are mainly focused on oncology, respiratory and dermatology.
Our branded generic business has a significant presence in the emerging economies market with India.
Generic business service requires a market like US and Western Europe. Our API business sells products in 80 countries across the US, EU, South America and India.
17 construction facilities and 5 R & D centers are devoted to the purpose of enriching the world's lifestyle, we believe that the real power behind our endless success is dedicated employees from 50 employees, dedicated to creating a 'new way for a new world'.
Glenmark Pharmaceutical Child Health:-
Healthy children are the foundation of a healthy world. By this faith we have started our flagship program, which is in the child's health area and has focused on pregnant mothers and children up to five years of age. A few years ago we had done extensive research in the field of child health. The important findings in this research led us to launch our main program called "Armor", under which we organize all our child health programs.
The word 'shield' means a shield that is a symbol of protection. Through our various interventions with our NGO partners, we aim to encourage positive health-seeking behavior in pregnant women, mothers with non-vegetarian children, and proper nutrition, good hygiene practices and overall criticism for children.
Glenmark Pharmaceutical Formulation overview:-
We have focused on developing and marketing branded and generic formulas. Our formulation business has spread mainly in different geographical regions of America, India, Europe, Latin America and the rest of the world. We focus on producing specific products in the therapeutic area of dermatology, respiration and oncology. We have 11 production facilities throughout India, America, Argentina and Czech Republic. The facility is available in the U.S.A. The FDA, MHRA is accredited by various regulatory bodies including the UK and Años Brazil. Being a research-driven organization, we have invested in dedicated R & D centers for global markets.
